Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Indivior (INDV)

Indivior eliminates Chief Scientific Officer role effective June 1, 2026

Neutral Impact 3 of 5 leadership Written later

Indivior will eliminate its Chief Scientific Officer position effective June 1, 2026. Dr. Christian Heidbreder will advise the CEO on special projects through the end of 2026, and his employment will end December 31, 2026 as a termination without cause. At the May 13, 2026 annual meeting, shareholders elected all eight director nominees, approved executive pay on an advisory basis, and ratified PricewaterhouseCoopers LLP as auditor for 2026.

Key points

  • Chief Scientific Officer position eliminated effective June 1, 2026
  • Dr. Christian Heidbreder's employment terminates December 31, 2026, treated as termination without cause
  • All eight director nominees elected to one-year terms ending at the 2027 annual meeting
  • Say-on-pay approved with 90,364,566 votes for and 1,324,996 against; 91,848,954 votes favored annual say-on-pay votes

The filing

CompanyIndivior (INDV)
Form8-K, current report
Filed with the SECMay 15, 2026, 4:01 PM ET
Accession number0001625297-26-000024

Items reported: 5.02 Director / Officer Change5.07 Shareholder Vote Results

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 2:07 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 15, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.